Gary W Middleton

18PUBLICATIONS
95CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer geneticsPredictive and prognostic markersTumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Jun 18, 2026
The anti-CD33 antibody drug conjugate gemtuzumab ozogamicin depletes and functionally resets CD33+ myeloid-derived suppressor cells in patients with metastatic cancer: a phase 2 single-arm, open-label trial.

|Nov 08, 2025
Experimental Cancer Medicine Centre (ECMC) network proposal for a consensus gene panel for pan-cancer sequencing: a Delphi methodology.

Richard Phillips, Bristi Basu, Zohra Butt

|Oct 31, 2024
The potential clinical utility of Whole Genome Sequencing for patients with cancer: evaluation of a regional implementation of the 100,000 Genomes Project.

Elaine Y L Leung, Helen L Robbins, Shafquat Zaman

|Jul 04, 2024
Author Correction: The evolution of lung cancer and impact of subclonal selection in TRACERx.

Alexander M Frankell, Michelle Dietzen, Maise Al Bakir

|Aug 11, 2023
MHC Class II is Induced by IFNγ and Follows Three Distinct Patterns of Expression in Colorectal Cancer Organoids.

Oliver J Pickles, Kasun Wanigasooriya, Anetta Ptasinska

|Apr 12, 2023
The evolution of lung cancer and impact of subclonal selection in TRACERx.

Alexander M Frankell, Michelle Dietzen, Maise Al Bakir

Pageof 3

Frequent Collaborators

6 joint publications

Charles Swanton

3 joint publications

Carlos Martínez-Ruiz

3 joint publications

David A Moore

3 joint publications

Maise Al Bakir